Oncorus

NEWS
Oncorus suspended operations in 2023.
Life sciences and biopharma companies strengthen their leadership teams and boards with these Movers & Shakers.
Process development and quality control will begin in 2021, and full manufacturing capabilities at the 88,000-square-foot facility will be available in 2023.
Pharma and life sciences companies strengthen their executive and leadership teams with this week’s appointments.
The round was co-led by Cowen Healthcare Investments and Perceptive Advisors.
Biopharma companies shore up leadership roles with new hires and appointments, at Axcella Health, Twist Bioscience, and more.
Biotech companies continue to adjust their leadership ranks and strengthen the members of their organization representing and overseeing the companies. Here is a look at some of those adjustments.
Oncorus, a biotechnology company based in Cambridge, Massachusetts, announced that Theodore (Ted) T. Ashburn had been chosen as the company’s new president and chief executive officer.
The uses of viruses as therapeutics is growing, largely because new gene therapy treatments require viruses.
BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.
AWARDS
  • NextGen Class of 2017
IN THE PRESS